World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Stem Cell-Gene Therapy Shows Promise in ALS Safety Trial

Stem Cell-Gene Therapy Shows Promise in ALS Safety Trial

by admin | Oct 2, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Cedars Sinai Cedars-Sinai Investigators Confirm Safety of a Novel Therapy Targeting Motor Neurons That Die in Patients With ALS Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered...
Untapped potential of stem cells could aid repair of spinal cord damage

Untapped potential of stem cells could aid repair of spinal cord damage

by admin | Oct 1, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

The Francis Crick Institute Scientists at the Francis Crick Institute have identified a group of latent stem cells that respond to injury in the central nervous system of mice. If a similar type of cell exists in humans, they could offer a new therapeutic approach to...
Drug shows promise for motor neuron disease

Drug shows promise for motor neuron disease

by admin | Sep 30, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By University of Cambridge A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease, according to a new study. Motor neuron disease (MND) is a group of rare diseases that destroy...
Auto Draft

Initiative Makes Stem Cell Lines Available for Research Worldwide

by admin | Sep 29, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Web portal marks new phase in the iPSC Neurodegenerative Disease Initiative by Lindsey Shapiro, PhD – ALS News Today A number of stem cell lines developed to better understand how certain genetic factors might contribute to amyotrophic lateral sclerosis (ALS)...
Mayo Clinic, National Resilience to create center for biomanufacturing regenerative technologies

Mayo Clinic, National Resilience to create center for biomanufacturing regenerative technologies

by admin | Sep 28, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By The Science Advisory Board staff writers August 16, 2022 — The Mayo Clinic and biotech company National Resilience have announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions, with a focus on...
Virtual Discussion Advancements Toward a Diabetes Cure

Virtual Discussion Advancements Toward a Diabetes Cure

by admin | Sep 27, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions, Video

JUST IN! Major breakthrough for Type 1 diabetes that will provide an endless source of stem cell derived #isletcells for transplantation! When fully developed and deployed, there will be no longer be a need for organ transplants. Renowned researcher, first author of...
Page 143 of 212« First«...102030...141142143144145...150160170...»Last »

Recent Posts

  • New Bio-Implant for Spinal Cord Repair
  • Seattle jury awards $24M in lawsuit against stem cell center
  • Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
  • After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
  • More Sensitive Cell Therapy May Be a HIT Against Solid Cancers
  • New iron nanomaterial wipes out cancer cells without harming healthy tissue
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow